Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccine in Patients with Hypersensitivity to First Dose
Abstract Two mRNA COVID-19 vaccines, Moderna and Pfizer-BioNTech, require two doses for maximum efficacy. This case series reports the safety and immunogenicity of a graded administration of the second dose of the Moderna or Pfizer-BioNTech COVID-19 vaccines in patients with immediate hypersensitivity reactions to the first dose.
Keyword(s):
2011 ◽
Vol 127
(2)
◽
pp. AB197-AB197
2018 ◽
Vol 141
(2)
◽
pp. AB35
2018 ◽
Vol 37
(1_suppl)
◽
pp. 55S-66S
◽